期刊文献+

原发性高血压病患者血同型半胱氨酸与尿微量蛋白关系研究 被引量:6

Relationship between serum homocysteine and urinary albumin in patients with essential hypertension
原文传递
导出
摘要 目的研究原发性高血压患者血同型半胱氨酸与尿微量蛋白之间的关系。方法将2010年7月至2011年12月期间在河南省人民医院住院的原发性高血压病患者(266例),按照血同型半胱氨酸(Hcy)水平的不同分为三组:A组88例(血Hcy〈15.0μmol/L),B组102例(15μmol/L≤Hcy〈20.0μmoL/L,),C组76例(≥20μm01)/L,分别测定并比较三组患者的尿微量蛋白,探究血同型半胱氨酸与尿微量蛋白的关系。结果三组高血压病患者,随着同型半胱氨酸水平的升高,尿微量蛋白亦升高,A组〈B组〈C组,组间比较差异有统计学意义(P〈0.05)。结论原发性高血压病患者血同型半胱氨酸与尿微量白蛋白之间具有相关性。 Objective To investigate the relationship between serum homocysteine(Hcy)and urinary albumin in patients with essential hypertension. Methods The 266 essential hypertensive patients with essential hypertensive recruited were treated between July 2007 and December 2011 in henan provincial people's hospital. They were divided into three groups according to serum homcoysteine: group A (Hcy 〈 15.0 μmo]/L), group B (15 μmol/L≤Hcy 〈20. 0 μmoL/L), group C( 320 μmol/L). To deterrain and compare the urinary albumin of the three groups and to explore the relationship between both. Results The difference was significant, urinary albumin level: group A 〈 group 13 〈 group C (P 〈 0. 05). The higher the homoeysteine level was, the higher the UAlb was. Conclusions In patients with essential hypertensive, UAlb is positively correlated with Hey.
作者 赫连曼 王浩
出处 《中国实用医刊》 2012年第23期23-25,共3页 Chinese Journal of Practical Medicine
关键词 原发性高血压病 血同型半胱氨酸 尿微量蛋白 Essential hypertension Homocysteine Urinary albumin
  • 相关文献

参考文献11

  • 1Jamison RL, Hartigan P, Kaufman JS,et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial[ J 1. JAMA, 2007,298(10) : 1163-1170.
  • 2Ruan L, Chen W, Sathanur R. Plasma homocysteine is adversely as sociated with glomerular filtration rate in asymptomatic black and white young adults: the Bogalusa heart study[ J ]. Eur J Epidemiol, 2009, 24(6) :315-319.
  • 3敖家富.血清同型半胱氨酸水平与高血压早期肾损害的关系分析[J].检验医学与临床,2009,6(23):2037-2038. 被引量:7
  • 4McCullough PA, Li S, 3urkovitz CT, et al. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality [ J ]. Am Heart J, 2008,156 (2) :277-283.
  • 5Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease : a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention [ J ]. Circulation, 2003, 108 ( 17 ) : 2154- 2169.
  • 6Menon V, Wang X, Wang X, Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins[ J]. Kidney International, 2005, 67(4): 1539-1546.
  • 7Diez N, Perez R, Hurtado V. Hyperhomocysteinaemia induced by dietary folate restriction causes kidney oxidative stress in rats [J]. Br J Nutr, 2005,94(2) : 204-210.
  • 8Stam F, van Guldener C, Ter Wee PM, et al. Effect of folic acid on me-thionine and homocysteine metabolism in end-stage renal disease [ J ]. Kidney Int, 2005,67(1): 259-264.
  • 9Winkelmayer WC, Kramar R, Curhan GC, et al. Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study[ J ]. J Am Soc Nephrol,2005,16 ( 1 ) : 255-260.
  • 10Woo CW, Siow YL, Pierce GN, et al. Hyperhomocysteinemia in- duces hepatic cholesterol biosynthesis and lipid accumulation via acti- vation of transcription factors [ J ]. Am J Physiol Endocrinol Metab, 2005,288 (5) : E1002-EIO10.

二级参考文献5

共引文献6

同被引文献72

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部